Kennedy Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.64M | Sell |
19,410
-1,047
| -5% | -$466K | 0.21% | 170 |
|
|
2025
Q1 | $9.92M | Sell |
20,457
-3,158
| -13% | -$1.53M | 0.24% | 146 |
|
|
2024
Q4 | $9.51M | Buy |
23,615
+10,084
| +75% | +$4.06M | 0.21% | 146 |
|
|
2024
Q3 | $6.29M | Buy |
13,531
+1,540
| +13% | +$716K | 0.14% | 257 |
|
|
2024
Q2 | $5.62M | Buy |
11,991
+3,680
| +44% | +$1.72M | 0.12% | 288 |
|
|
2024
Q1 | $3.47M | Buy |
+8,311
| New | +$3.47M | 0.07% | 409 |
|